Story · Medicine & Biotech · Mind & Brain

How a CRISPR sickle cell therapy moved from lab to clinical trial

1 outlet · first reported by Medical Xpress 7d ago

Coverage, in order

  1. 7d ago
    Medical Xpress indie study
    How a CRISPR sickle cell therapy moved from lab to clinical trial

    A UCLA-led team has described how it advanced an experimental CRISPR approach for sickle cell disease into a blood stem cell therapy that can be manufactured at the scale and quality required for a clinical trial.

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.